# Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

> **NCT02780362** · PHASE1 · COMPLETED · sponsor: **Genuine Research Center, Egypt** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Prodactariv
- **DRUG:** Clatazev

## Key facts

- **NCT ID:** NCT02780362
- **Lead sponsor:** Genuine Research Center, Egypt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-05-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02780362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02780362, "Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02780362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*